^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^d Tested in sodium chloride 0.45%.

^e Test performed using the formulation WITH edetate disodium.

^f Test performed using the formulation WITHOUT edetate disodium.

^g Specific composition of the parenteral nutrition admixture not reported. TPN indicates a 2-in-1 admixture.

^h Tested in Ringer’s injection, lactated.

ⁱ Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^j Quinupristin and dalfopristin components combined.

^k Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

^l Not specified whether concentration refers to single component or combined components.

^m Presence or absence of edetate disodium not specified.

ⁿ Tested in both dextrose 5% and sodium chloride 0.9%.

^o Test performed using the Cubicin formulation.

^p Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^q Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^r Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.